The fiscal year 2025 closed with a dramatic reshuffling at the pinnacle of the pharmaceutical industry’s sales leaderboard, signaling profound…
Read More
Insilico Medicine and Eli Lilly Forge Potentially $2.75 Billion AI-Driven Drug Discovery Alliance, Signaling a New Era of Pharmaceutical Innovation
On March 29, Insilico Medicine, a pioneering company in artificial intelligence-driven drug discovery and development, announced a landmark collaboration with…
Read More
Amazon Bio Discovery cut MSK antibody design from a year to weeks, AWS says
Amazon Web Services (AWS) has announced the launch of Amazon Bio Discovery, a groundbreaking application poised to revolutionize drug discovery…
Read More
How Immuto Scientific Pairs AI and Mass Spec for a Step Change in Protein Structure Throughput
Immuto Scientific, a pioneering biotechnology firm co-founded in 2018 by electrical engineers Faraz A. Choudhury, Ph.D. (CEO), and Daniel Benjamin,…
Read More
Lilly’s plans to buy CAR-T firm Kelonia in deal worth up to $7 billion. Can its deal spree avoid Pfizer’s fate?
Eli Lilly and Company, currently riding an unprecedented wave of success fueled by its GLP-1 franchise, has announced its intent…
Read More
Rethinking evidence generation for ultra-rare diseases
Developing treatments for the approximately 7,000 known rare diseases, particularly the subset classified as ultra-rare, presents profound and often insurmountable…
Read More
Fake testimonials, no pharmacy and an FDA warning: how Medvi built a $1.8 billion telehealth company in the gaps between regulators
The recent trajectory of Medvi, a telehealth company projected to achieve a staggering $1.8 billion valuation this year, casts a…
Read More
Protecting Innovation in a Borderless Pharma Economy: The Reality of Globalized Pharma Innovation
Today’s pharmaceutical landscape is characterized by drug development programs that routinely span continents, involving distributed research teams, multinational clinical trial…
Read More
Top pharma companies set sustainability goals, but emissions are still increasing
The global healthcare industry stands as a significant contributor to the planet’s carbon footprint, accounting for an estimated 4.4% of…
Read More
Traumatic brain injury and Alzheimer’s disease, common neuroinflammatory pathologies and therapeutic potential
Traumatic Brain Injury (TBI) stands as a formidable global public health crisis, impacting an estimated 69 million individuals annually across…
Read More
